Rafferty Asset Management
NVAX icon

Rafferty Asset Management’s Novavax NVAX Stock Holding History

Rafferty Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Sell
208,696
-39,717
-16% -$356K ﹤0.01% 648
2026
Q1 		$2.02M Sell
248,413
-81,073
-25% -$735K 0.01% 607
2025
Q4 		$2.21M Buy
329,486
+71,000
+27% +$535K 0.01% 626
2025
Q3 		$2.24M Buy
258,486
+4,472
+2% +$34.8K 0.01% 624
2025
Q2 		$1.6M Sell
254,014
-23,701
-9% -$157K 0.01% 662
2025
Q1 		$1.78M Sell
277,715
-80,502
-22% -$665K 0.01% 605
2024
Q4 		$2.88M Sell
358,217
-17,227
-5% -$166K 0.01% 540
2024
Q3 		$4.74M Buy
375,444
+113,572
+43% +$1.47M 0.02% 437
2024
Q2 		$3.32M Sell
261,872
-1,420,787
-84% -$14.3M 0.01% 506
2024
Q1 		$8.04M Buy
1,682,659
+70,819
+4% +$328K 0.03% 344
2023
Q4 		$7.74M Buy
1,611,840
+619,370
+62% +$3.79M 0.03% 340
2023
Q3 		$7.19M Sell
992,470
-119,603
-11% -$956K 0.04% 314
2023
Q2 		$8.26M Buy
1,112,073
+68,796
+7% +$541K 0.05% 259
2023
Q1 		$7.23M Buy
1,043,277
+554,753
+114% +$5.1M 0.05% 280
2022
Q4 		$5.02M Buy
488,524
+270,106
+124% +$4.77M 0.04% 372
2022
Q3 		$3.98M Buy
218,418
+124,401
+132% +$5.39M 0.04% 372
2022
Q2 		$4.83M Buy
94,017
+20,756
+28% +$1.08M 0.04% 281
2022
Q1 		$5.4M Buy
73,261
+41,601
+131% +$3.71M 0.03% 372
2021
Q4 		$4.53M Buy
31,660
+18,796
+146% +$3.23M 0.02% 421
2021
Q3 		$2.67M Buy
12,864
+425
+3% +$93.7K 0.02% 543
2021
Q2 		$2.64M Sell
12,439
-4,007
-24% -$734K 0.02% 559
2021
Q1 		$2.98M Buy
16,446
+8,981
+120% +$1.79M 0.02% 501
2020
Q4 		$832K Sell
7,465
-13,323
-64% -$1.42M 0.01% 558
2020
Q3 		$2.25M Sell
20,788
-170
-0.8% -$20.7K 0.03% 376
2020
Q2 		$1.75M Buy
+20,958
New +$802K 0.02% 385

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Rafferty Asset Management's NVAX Position: Q2 2026 in Review

Rafferty Asset Management reduced its Novavax (NVAX) stake by 16% in Q2 2026, selling an estimated $356K and leaving 208,696 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #648.

Rafferty Asset Management first reported a position in NVAX in Q2 2020 and has held it in 25 quarters since. The position peaked at $8.26M in Q2 2023. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Rafferty Asset Management held 208,696 shares of Novavax worth $1.97M as of Q2 2026.
  • Rafferty Asset Management sold 39,717 Novavax shares in Q2 2026, an estimated $356K.
  • Novavax made up ﹤0.01% of Rafferty Asset Management's portfolio in Q2 2026, its #648 holding.
  • Rafferty Asset Management first reported a position in Novavax in Q2 2020 and has held it in 25 quarters since.
  • Rafferty Asset Management's Novavax position peaked at $8.26M in Q2 2023.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Rafferty Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.